pyrroles has been researched along with Sleepiness in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beneš, H; De Boer, P; Dorffner, G; Drevets, WC; Jahn, H; Keicher, C; Kent, JM; Kezic, I; Luthringer, R; Parapatics, S; Rofael, H; Seiden, DJ; van der Ark, P; van Gerven, J | 1 |
| de Boer, P; Golor, G; Nandy, P; van der Ark, PD; van Nueten, L | 1 |
2 trial(s) available for pyrroles and Sleepiness
| Article | Year |
|---|---|
A randomized Phase 2 study to evaluate the orexin-2 receptor antagonist seltorexant in individuals with insomnia without psychiatric comorbidity.
Topics: Adult; Cross-Over Studies; Double-Blind Method; Female; Headache; Humans; Male; Middle Aged; Orexin Receptor Antagonists; Orexin Receptors; Polysomnography; Pyrimidines; Pyrroles; Sleep; Sleep Initiation and Maintenance Disorders; Sleepiness; Surveys and Questionnaires; Time Factors; Treatment Outcome; Triazoles; Young Adult | 2018 |
Multiple daytime administration of the selective orexin-2 receptor antagonist JNJ-42847922 induces somnolence in healthy subjects without residual central effects.
Topics: Administration, Oral; Adolescent; Adult; Area Under Curve; Dose-Response Relationship, Drug; Double-Blind Method; Female; Half-Life; Humans; Male; Middle Aged; Orexin Receptor Antagonists; Orexin Receptors; Pyrimidines; Pyrroles; Sleepiness; Time Factors; Triazoles; Young Adult | 2018 |